Serial Number
98562943
Owner
GENUITI THERAPEUTICS, INC.Attorney
Aaron D. HendelmanFiling Date
May 22, 2024
GENUITI Trademark
Serial Number: 98562943
Trademark Classes
Owner Contact Info
Legal Representation
Correspondence Address
Aaron D. Hendelman Wilson Sonsini Goodrich & Rosati
650 Page Mill Road
Palo Alto, CA 94304-1050
United States
Trademark Details
Filing Date
May 22, 2024
Registration Date
Not Registered
Goods & Services
scientific research for medical purposes in the fields of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development of therapeutics for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development in the field of small molecule drug discovery; medical and scientific research in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical products development in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; drug discovery services in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical research and development services in the field of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; research and development in the field of precision medicine; none of the foregoing for use related to DNA or RNA screening or analysis services or software
therapeutic pharmaceuticals for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical products for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceutical preparations for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; pharmaceuticals comprising small molecules for the treatment of obesity and metabolic diseases, eye diseases, mitochondrial diseases, pulmonary hypertension, metabolic syndromes; none of the foregoing for use related to DNA or RNA screening or analysis services or software